8-K: Select Medical Receives Take-Private Offer from Chairman

Select Medical Holdings Corporation acknowledges a non-binding take-private proposal from its Executive Chairman, Robert A. Ortenzio, for $16.00 to $16.20 per share.

Summary

• Select Medical Holdings Corporation (NYSE: SEM) received a non-binding indication of interest from its Executive Chairman, Co-Founder, and Director, Robert A. Ortenzio.
• The proposal is to acquire all outstanding shares of Select Medical for cash consideration ranging from $16.00 to $16.20 per share.
• Mr. Ortenzio publicly disclosed this proposal in a Schedule 13D filing with the U.S. Securities and Exchange Commission on November 24, 2025.
• The disinterested members of the Board of Directors are currently reviewing and evaluating the proposal in consultation with their advisors.
• The Board is committed to acting in the best interests of Select Medical and its stockholders.
• Select Medical operates 105 critical illness recovery hospitals, 36 rehabilitation hospitals, and 1,922 outpatient rehabilitation clinics across 40 states and the District of Columbia as of September 30, 2025.

Sentiment

Score: 7

Explanation: The proposal offers a potential premium to shareholders, which is positive. However, the non-binding nature and uncertainty surrounding the outcome introduce a degree of caution.

Positives

• The proposal offers a cash consideration of $16.00 to $16.20 per share, potentially providing a premium to current shareholders.
• The Board's disinterested members are actively reviewing the proposal, indicating a commitment to shareholder interests.

Negatives

• The proposal is non-binding, meaning there is no guarantee it will lead to a definitive agreement or transaction.
• The company does not intend to comment further until additional disclosure is appropriate or legally required, leading to uncertainty for investors.

Risks

• There is no assurance that the non-binding proposal will result in any particular outcome, including a definitive agreement or transaction.
• The proposal involves a related party (Executive Chairman), which could raise potential conflicts of interest, though the disinterested board members are reviewing it.
• Market speculation and volatility may occur due to the uncertainty surrounding the proposal.

Future Outlook

The company explicitly states that there can be no assurance that the non-binding proposal will result in any particular outcome and does not intend to comment further until additional disclosure is appropriate or required by law. This indicates a highly uncertain future regarding the proposal's completion.

Management Comments

• "The disinterested members of the Board of Directors of Select Medical are carefully reviewing and evaluating the Proposal in consultation with their advisors and are committed to acting in the best interests of Select Medical and its stockholders."

Industry Context

The healthcare services industry, particularly specialized care facilities like critical illness recovery and rehabilitation hospitals, often attracts interest from private equity or strategic buyers seeking stable cash flows and consolidation opportunities. A take-private offer from an insider suggests a belief in the company's intrinsic value potentially being undervalued by the public market.

Corporate Governance

Related Party Transactions

• The non-binding indication of interest was submitted by Robert A. Ortenzio, the company's Executive Chairman, Co-Founder, and Director, making it a related-party transaction.

Stakeholder Impact

• Shareholders: Potential for a cash payout at a premium if the proposal is accepted and completed. Uncertainty exists until a definitive agreement is reached.
• Employees: No immediate impact mentioned, but a take-private transaction could lead to future operational changes.
• Customers/Suppliers: No immediate impact mentioned.

Next Steps

• The disinterested members of the Board of Directors will continue to review and evaluate the non-binding proposal.
• The company will only provide further comments or disclosures if deemed appropriate or required by law.

Key Dates

Recommendation

The non-binding nature of the proposal and the uncertainty of its outcome suggest a "hold" recommendation. While the offer price range is attractive, there is no guarantee of completion. Investors should await further developments from the Board's review process. Selling now might forgo potential upside if a higher offer emerges or the deal closes, while buying now carries the risk of the deal falling through and the stock price reverting.

Keywords

Select Medical, SEM, take-private, acquisition, Robert A. Ortenzio, healthcare services, critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, Schedule 13D, tender offer, merger and acquisition